Bausch & Lomb BLCO
NYSE BLCO
$17.56 -0.23 (-1.29%)
As of: Sep 10, 2026 · 3:59 PM EDT

Bausch & Lomb (BLCO) Operating Income (2021 - 2026)

Bausch & Lomb's (BLCO) quarterly Operating Income came in at $83.0 million in Q2 2026, up 854.55% on a YoY basis from $8.7 million in Q2 2025, and up 151.52% quarter-over-quarter from $33.0 million in Q1 2026.

Analysis

Bausch & Lomb (BLCO) Operating Income (2021 - 2026) Analysis & Trends

Bausch & Lomb (BLCO) has reported Operating Income for 6 consecutive years, with $83.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Operating Income rose 854.55% year-over-year to $83.0 million; the trailing twelve-month figure through Jun 2026 stood at $323.0 million (up 797.22% YoY), and the FY2025 full-year result was $113.0 million, down 30.25% from the prior year.
  • Operating Income advanced to $83.0 million in Q2 2026 per BLCO's latest filing, from $33.0 million in the prior quarter.
  • Across five years, Operating Income topped out at $112.0 million in Q4 2025 and bottomed at -$83.0 million in Q1 2025.
  • Historically, Operating Income has averaged $40.4 million across 5 years, with a median of $44.5 million in 2022.
  • The sharpest annual moves came in 2025 and 2026: Operating Income sank 1483.33% in 2025, then jumped 854.55% in 2026.
  • Over 5 years, Operating Income stood at $51.0 million in 2022, then decreased by 3.92% to $49.0 million in 2023, then surged by 77.55% to $87.0 million in 2024, then climbed by 28.74% to $112.0 million in 2025, then decreased by 25.89% to $83.0 million in 2026.
  • According to Business Quant data, Operating Income over the past three periods registered $83.0 million, $33.0 million, and $112.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 1.69 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 971.90 Mn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 1.76 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 1.66 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 1.18 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 513.20 Mn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 11.00 Mn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 318.30 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 285.80 Mn
10 Bausch & Lomb 6.28 Bn 5.90 Bn 867.00 Mn 83.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 83.00 Mn
Mar 31, 2026 33.00 Mn
Dec 31, 2025 112.00 Mn
Sep 30, 2025 95.00 Mn
Jun 30, 2025 -11.00 Mn
Mar 31, 2025 -83.00 Mn
Dec 31, 2024 87.00 Mn
Sep 30, 2024 43.00 Mn
Jun 30, 2024 26.00 Mn
Mar 31, 2024 6.00 Mn
Dec 31, 2023 49.00 Mn
Sep 30, 2023 40.00 Mn
Jun 30, 2023 43.00 Mn
Mar 31, 2023 -2.00 Mn
Dec 31, 2022 51.00 Mn
Sep 30, 2022 46.00 Mn
Jun 30, 2022 56.00 Mn
Mar 31, 2022 54.00 Mn
Dec 31, 2021 92.00 Mn
Sep 30, 2021 94.00 Mn